Kassanjee Reshma, McWalter Thomas A, Welte Alex
1 The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch , Stellenbosch, South Africa .
AIDS Res Hum Retroviruses. 2014 Jan;30(1):45-9. doi: 10.1089/aid.2013.0113. Epub 2013 Oct 26.
The estimation of HIV incidence from cross-sectional surveys using tests for recent infection has attracted much interest. It is increasingly recognized that the lack of high performance recent infection tests is hindering the implementation of this surveillance approach. With growing funding opportunities, test developers are currently trying to fill this gap. However, there is a lack of consensus and clear guidance for developers on the evaluation and optimization of candidate tests. A fundamental shift from conventional thinking about test performance is needed: away from metrics relevant in typical public health settings where the detection of a condition in individuals is of primary interest (sensitivity, specificity, and predictive values) and toward metrics that are appropriate when estimating a population-level parameter such as incidence (accuracy and precision). The inappropriate use of individual-level diagnostics performance measures could lead to spurious assessments and suboptimal designs of tests for incidence estimation. In some contexts, such as population-level application to HIV incidence, bias of estimates is essentially negligible, and all that remains is the maximization of precision. The maximization of the precision of incidence estimates provides a completely general criterion for test developers to assess and optimize test designs. Summarizing the test dynamics into the properties relevant for incidence estimation, high precision estimates are obtained when (1) the mean duration of recent infection is large, and (2) the false-recent rate is small. The optimal trade-off between these two test properties will produce the highest precision, and therefore the most epidemiologically useful incidence estimates.
利用近期感染检测方法通过横断面调查来估计艾滋病毒发病率已引起广泛关注。人们越来越认识到,缺乏高性能的近期感染检测方法正阻碍着这种监测方法的实施。随着资金机会的增加,检测方法开发者目前正试图填补这一空白。然而,在候选检测方法的评估和优化方面,开发者缺乏共识和明确的指导。需要从对检测性能的传统思维方式上进行根本性转变:从典型公共卫生环境中与个体疾病检测相关的指标(敏感性、特异性和预测值)转向在估计发病率等人群水平参数时适用的指标(准确性和精密度)。不恰当地使用个体水平的诊断性能指标可能会导致虚假评估以及发病率估计检测方法的次优设计。在某些情况下,比如在艾滋病毒发病率的人群水平应用中,估计偏差基本上可以忽略不计,剩下的就是精密度的最大化。发病率估计精密度的最大化提供了一个完全通用的标准,供检测方法开发者评估和优化检测设计。将检测动态归纳为与发病率估计相关的特性,当(1)近期感染的平均持续时间较长,以及(2)假近期感染率较低时,可获得高精度估计值。这两种检测特性之间的最佳权衡将产生最高的精密度,从而得到在流行病学上最有用的发病率估计值。